Search

Author/Creator Cescon, Terrence P.

1. Axitinib and/or bevacizumab with modified FOLFOX‐6 as first‐line therapy for metastatic colorectal cancer: A randomized phase 2 study. Issue 14 (19th April 2013)

Authors:
Infante, Jeffrey R.; Reid, Tony R.; Cohn, Allen L.; Edenfield, William J.; Cescon, Terrence P.; Hamm, John T.; Malik, Imtiaz A.; Rado, Thomas A.; McGee, Philip J.; Richards, Donald A.; Tarazi, Jamal; Rosbrook, Brad; Kim, Sinil; Cartwright, Thomas H.
Journal:
Cancer
Issue:
Volume 119:Issue 14(2013)
Page Start:
2555
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Axitinib and/or bevacizumab with modified FOLFOX‐6 as first‐line therapy for metastatic colorectal cancer: A randomized phase 2 study. Issue 14 (19th April 2013)

Authors:
Infante, Jeffrey R.; Reid, Tony R.; Cohn, Allen L.; Edenfield, William J.; Cescon, Terrence P.; Hamm, John T.; Malik, Imtiaz A.; Rado, Thomas A.; McGee, Philip J.; Richards, Donald A.; Tarazi, Jamal; Rosbrook, Brad; Kim, Sinil; Cartwright, Thomas H.
Journal:
Cancer
Issue:
Volume 119:Issue 14(2013)
Page Start:
2555
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search